{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:25:12Z","timestamp":1793064312280,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The benefit of MR-only workflow compared to current CT-based workflow for prostate radiotherapy is reduction of systematic errors in the radiotherapy chain by 2\u20133\u00a0mm. Nowadays, MRI is used for target delineation while CT is needed for position verification. In MR-only workflows, MRI based synthetic CT (sCT) replaces CT. Intraprostatic fiducial markers (FMs) are used as a surrogate for the position of the prostate improving targeting. However, FMs are not visible on sCT. Therefore, a semi-automatic method for burning-in FMs on sCT was developed. Accuracy of MR-only workflow using semi-automatically burned-in FMs was assessed and compared to CT\/MR workflow.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-one prostate cancer patients receiving radiotherapy, underwent an additional MR sequence (mDIXON) to create an sCT for MR-only workflow simulation. Three sources of accuracy in the CT\/MR- and MR-only workflow were investigated. To compare image registrations for target delineation, the inter-observer error (IOE) of FM-based CT-to-MR image registrations and soft-tissue-based MR-to-MR image registrations were determined on twenty patients. Secondly, the inter-observer variation of the resulting FM positions was determined on twenty patients. Thirdly, on 26 patients CBCTs were retrospectively registered on sCT with burned-in FMs and compared to CT-CBCT registrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Image registration for target delineation shows a three times smaller IOE for MR-only workflow compared to CT\/MR workflow. All observers agreed in correctly identifying all FMs for 18 out of 20 patients (90%). The IOE in CC direction of the center of mass (COM) position of the markers was within the CT slice thickness (2.5\u00a0mm), the IOE in AP and RL direction were below 1.0\u00a0mm and 1.5\u00a0mm, respectively. Registrations for IGRT position verification in MR-only workflow compared to CT\/MR workflow were equivalent in RL-, CC- and AP-direction, except for a significant difference for random error in rotation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MR-only workflow using sCT with burned-in FMs is an improvement compared to the current CT\/MR workflow, with a three times smaller inter observer error in CT-MR registration and comparable CBCT registration results between CT and sCT reference scans.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registry<\/jats:italic>\n                      Medical Research Involving Human Subjects Act (WMO) does apply to this study and was approved by the Medical Ethics review Committee of the Academic Medical Center. Registration number: NL65414.018.18. Date of registration: 21\u201308-2018.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-021-01768-8","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T15:13:38Z","timestamp":1613834018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-2679","authenticated-orcid":false,"given":"Karin","family":"Goudschaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Beeksma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bijveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"van Kesteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"issue":"1","key":"1768_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-017-0854-4","volume":"12","author":"N Tyagi","year":"2017","unstructured":"Tyagi N, Fontenla S, Zelefsky M, Chong-Ton M, Ostergren K, Shah N, et al. Clinical workflow for MR-only simulation and planning in prostate. Radiat Oncol. 2017;12(1):1\u201312.","journal-title":"Radiat Oncol"},{"issue":"5","key":"1768_CR2","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1118\/1.4944871","volume":"43","author":"S Ghose","year":"2016","unstructured":"Ghose S, Mitra J, Rivest-H\u00e9nault D, Fazlollahi A, Stanwell P, Pichler P, et al. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection. Med Phys. 2016;43(5):2218\u201328.","journal-title":"Med Phys"},{"key":"1768_CR3","unstructured":"K\u00f6hler M, Vaara T, Grootel M Van, Hoogeveen R, Kemppainen R, Renisch S. White paper: MR-only simulation for radiotherapy planning. Philips [Internet]. 2015;1\u201316. Available from: http:\/\/incenter.medical.philips.com\/doclib\/getDoc.aspx?func=ll&objId=11228039&objAction=Open"},{"key":"1768_CR4","doi-asserted-by":"crossref","unstructured":"Davies. Clinical Applications for Diffusion MRI in Radiotherapy Christina. Semin Radiat Oncol. 2014;24(3):218\u201326.","DOI":"10.1016\/j.semradonc.2014.02.004"},{"issue":"1","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0360-3016(98)00351-4","volume":"43","author":"C Rasch","year":"1999","unstructured":"Rasch C, Barillot I, Remeijer P, Touw A, Van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: A multi-observer study. Int J Radiat Oncol Biol Phys. 1999;43(1):57\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1768_CR6","doi-asserted-by":"crossref","unstructured":"Khoo VS, Padhani AR, Tanner SF, Finnigan DJ, Leach MO, Dearnaley DP. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: A feasibility study. Br J Radiol. 1999;72(JUN.):590\u20137.","DOI":"10.1259\/bjr.72.858.10560342"},{"key":"1768_CR7","doi-asserted-by":"publisher","unstructured":"Dinis Fernandes C, Dinh C V., Steggerda MJ, ter Beek LC, Smolic M, van Buuren LD, et al. Prostate fiducial marker detection with the use of multi-parametric magnetic resonance imaging. Phys Imaging Radiat Oncol [Internet]. 2017;1(July 2018):14\u201320. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.phro.2017.02.001","DOI":"10.1016\/j.phro.2017.02.001"},{"issue":"1","key":"1768_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1148\/radiol.2361040560","volume":"236","author":"HJ Huisman","year":"2005","unstructured":"Huisman HJ, F\u00fctterer JJ, Van Lin ENJT, Welmers A, Scheenen TWJ, Van Dalen JA, et al. Prostate cancer: Precision of integrating functional MR imaging with radiation therapy treatment by using fiducial gold markers. Radiology. 2005;236(1):311\u20137.","journal-title":"Radiology"},{"key":"1768_CR9","doi-asserted-by":"publisher","unstructured":"Johnstone E, Wyatt JJ, Henry AM, Short SC, Sebag-Montefiore D, Murray L, et al. Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging\u2013Only Radiation Therapy. Int J Radiat Oncol Biol Phys [Internet]. 2018;100(1):199\u2013217. Available from: https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.043","DOI":"10.1016\/j.ijrobp.2017.08.043"},{"issue":"5","key":"1768_CR10","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.ijrobp.2011.01.046","volume":"82","author":"JH Jonsson","year":"2012","unstructured":"Jonsson JH, Garpebring A, Karlsson MG, Nyholm T. Internal fiducial markers and susceptibility effects in MRI - Simulation and measurement of spatial accuracy. Int J Radiat Oncol Biol Phys. 2012;82(5):1612\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1768_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.semradonc.2003.10.003","volume":"14","author":"M Van Herk","year":"2004","unstructured":"Van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14(1):52\u201364.","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"1768_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1088\/1361-6560\/aaaca4","volume":"63","author":"AM Owrangi","year":"2018","unstructured":"Owrangi AM, Greer PB, Glide-Hurst CK. MRI-only treatment planning: Benefits and challenges. Phys Med Biol. 2018;63(5):1\u201330.","journal-title":"Phys Med Biol"},{"key":"1768_CR13","doi-asserted-by":"crossref","unstructured":"Nyholm T, Nyberg M, Karlsson MG, Karlsson M. Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiat Oncol. 2009;4(1).","DOI":"10.1186\/1748-717X-4-54"},{"key":"1768_CR14","doi-asserted-by":"publisher","unstructured":"Tenhunen M, Korhonen J, Kapanen M, Sepp\u00e4l\u00e4 T, Koivula L, Collan J, et al. MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience. Acta Oncol (Madr) [Internet]. 2018;57(7):902\u20137. Available from: https:\/\/doi.org\/https:\/\/doi.org\/10.1080\/0284186X.2018.1445284","DOI":"10.1080\/0284186X.2018.1445284"},{"issue":"1","key":"1768_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11604-016-0590-y","volume":"35","author":"BA Yildirim","year":"2017","unstructured":"Yildirim BA, Onal C, Dolek Y. Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients? Jpn J Radiol. 2017;35(1):3\u20139.","journal-title":"Jpn J Radiol"},{"issue":"02","key":"1768_CR16","first-page":"75","volume":"00","author":"CD Fuller","year":"2006","unstructured":"Fuller CD, Scarbrough TJ. Fiducial Markers in Image-guided Radiotherapy of the Prostate. Oncol Hematol Rev. 2006;00(02):75.","journal-title":"Oncol Hematol Rev"},{"key":"1768_CR17","doi-asserted-by":"crossref","unstructured":"O\u2019neill AGM, Jain S, Hounsell AR, O\u2019sullivan JM. Fiducial marker guided prostate radiotherapy: A review. Br J Radiol. 2016;89(1068):1\u201318.","DOI":"10.1259\/bjr.20160296"},{"issue":"1","key":"1768_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/1754-9485.12197","volume":"59","author":"T Deegan","year":"2015","unstructured":"Deegan T, Owen R, Holt T, Fielding A, Biggs J, Parfitt M, et al. Assessment of cone beam CT registration for prostate radiation therapy: Fiducial marker and soft tissue methods. J Med Imaging Radiat Oncol. 2015;59(1):91\u20138.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1768_CR19","doi-asserted-by":"publisher","unstructured":"Alexander SE, Kinsella J, McNair HA, Tree AC. National survey of fiducial marker insertion for prostate image guided radiotherapy. Radiography [Internet]. 2018;24(4):275\u201382. https:\/\/doi.org\/10.1016\/j.radi.2018.06.003","DOI":"10.1016\/j.radi.2018.06.003"},{"issue":"20","key":"1768_CR20","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1088\/1361-6560\/aa875f","volume":"62","author":"M Maspero","year":"2017","unstructured":"Maspero M, Van Den Berg CAT, Zijlstra F, Sikkes GG, De Boer HCJ, Meijer GJ, et al. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy. Phys Med Biol. 2017;62(20):7981\u20138002.","journal-title":"Phys Med Biol"},{"issue":"1","key":"1768_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.radonc.2006.11.002","volume":"82","author":"UA van der Heide","year":"2007","unstructured":"van der Heide UA, Kotte ANTJ, Dehnad H, Hofman P, Lagenijk JJW, van Vulpen M. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol. 2007;82(1):38\u201345.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1768_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semradonc.2007.09.008","volume":"18","author":"PA Kupelian","year":"2008","unstructured":"Kupelian PA, Langen KM, Willoughby TR, Zeidan OA, Meeks SL. Image-Guided Radiotherapy for Localized Prostate Cancer: Treating a Moving Target. Semin Radiat Oncol. 2008;18(1):58\u201366.","journal-title":"Semin Radiat Oncol"},{"key":"1768_CR23","doi-asserted-by":"publisher","unstructured":"Ghadjar P, Fiorino C, Munck af Rosensch\u00f6ld P, Pinkawa M, Zilli T, van der Heide UA. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiother Oncol [Internet]. 2019;141:5\u201313. https:\/\/doi.org\/10.1016\/j.radonc.2019.08.027","DOI":"10.1016\/j.radonc.2019.08.027"},{"issue":"11","key":"1768_CR24","first-page":"5563","volume":"44","author":"C Gustafsson","year":"2017","unstructured":"Gustafsson C, Korhonen J, Persson E, Gunnlaugsson A, Nyholm T, Olsson LE. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy: Med Phys. 2017;44(11):5563\u201374.","journal-title":"Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy: Med Phys"},{"issue":"8","key":"1768_CR25","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1088\/1361-6560\/aa5452","volume":"62","author":"N Tyagi","year":"2017","unstructured":"Tyagi N, Fontenla S, Zhang J, Cloutier M, Kadbi M, Mechalakos J, et al. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis. Phys Med Biol. 2017;62(8):2961\u201375.","journal-title":"Phys Med Biol"},{"issue":"6","key":"1768_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/0284186X.2017.1290275","volume":"56","author":"RL Christiansen","year":"2017","unstructured":"Christiansen RL, Jensen HR, Brink C. Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer. Acta Oncol (Madr). 2017;56(6):787\u201391.","journal-title":"Acta Oncol (Madr)"},{"key":"1768_CR27","doi-asserted-by":"publisher","unstructured":"Bird D, Henry AM, Sebag-Montefiore D, Buckley DL, Al-Qaisieh B, Speight R. A Systematic Review of the Clinical Implementation of Pelvic Magnetic Resonance Imaging\u2013Only Planning for External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys [Internet]. 2019;105(3):479\u201392. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2530","DOI":"10.1016\/j.ijrobp.2019.06.2530"},{"key":"1768_CR28","unstructured":"EAU-ESTRO Guideline prostate cancer [Internet]. 2016. Available from: http:\/\/uroweb.org\/wpcontent\/uploads\/EAUGuidelinesProstate-Cancer-2016.pdf"},{"issue":"5","key":"1768_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4111\/kju.2012.53.5.330","volume":"53","author":"CG Hong","year":"2012","unstructured":"Hong CG, Yoon BI, Choe HS, Ha US, Sohn DW, Cho YH. The prevalence and characteristic differences in prostatic calcification between health promotion center and urology department outpatients. Korean J Urol. 2012;53(5):330\u20134.","journal-title":"Korean J Urol"},{"key":"1768_CR30","doi-asserted-by":"crossref","unstructured":"Ullrich T, Quentin M, Oelers C, Dietzel F, Sawicki LM, Arsov C, et al. Magnetic resonance imaging of the prostate at 1.5 versus 3.0\u00a0T: A prospective comparison study of image quality. Vol. 90, European Journal of Radiology. 2017. p. 192\u20137.","DOI":"10.1016\/j.ejrad.2017.02.044"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01768-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01768-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:06:17Z","timestamp":1638795977000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01768-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01768-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-127932\/v1","asserted-by":"object"}]},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional ethics committee granted an exemption from requiring ethics approval in this study (NL65414.018.18; Academic Medical Center, University of Amsterdam, Amsterdam, NL).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Figures depicting individual person\u2019s data are unidentifiable and there are no details on individuals reported within the manuscript. Therefore, separate consent for publication is not deemed necessary for the figures shown in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. Dr. van Kesteren has research agreements with Varian and Philips Healthcare. Both industries were not a member of the research team and did not influence this study in any way.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}